Thelansis

  Bronchiolitis obliterans syndrome, also known as obliterative bronchiolitis or constrictive bronchiolitis. When it occurs after a lung transplantation or hematopoietic stem cell transplantation (HSCT), it is specifically referred to as bronchiolitis obliterans syndrome. Bronchiolitis obliterans is a type of obstructive lung disease of the small airways, a form of chronic allograft rejection after lung transplantation. The most of lung transplant recipients who are long-term survivors develop bronchiolitis obliterans syndrome. It is estimated that more than 50% of recipients will develop some degree of BO within 5 years post-transplant, with an average time to diagnosis of 16 to 20 months after lung transplant, although it has been reported as early as 3 months after transplantation. Bronchiolitis obliterans characteristically presents with dyspnea and a cough that is persistent and progressive. Some may also have wheezing. Unlike asthma, these symptoms usually develop over week...

 Bronchiolitis obliterans syndrome, also known as obliterative bronchiolitis or constrictive bronchiolitis. When it occurs after a lung transplantation or hematopoietic stem cell transplantation (HSCT), it is specifically referred to as bronchiolitis obliterans syndrome. Bronchiolitis obliterans is a type of obstructive lung disease of the small airways, a form of chronic allograft rejection after lung transplantation. The most of lung transplant recipients who are long-term survivors develop bronchiolitis obliterans syndrome. It is estimated that more than 50% of recipients will develop some degree of BO within 5 years post-transplant, with an average time to diagnosis of 16 to 20 months after lung transplant, although it has been reported as early as 3 months after transplantation. Bronchiolitis obliterans characteristically presents with dyspnea and a cough that is persistent and progressive. Some may also have wheezing. Unlike asthma, these symptoms usually develop over weeks t...

 Bronchiolitis obliterans syndrome, also known as obliterative bronchiolitis or constrictive bronchiolitis. When it occurs after a lung transplantation or hematopoietic stem cell transplantation (HSCT), it is specifically referred to as bronchiolitis obliterans syndrome. Bronchiolitis obliterans is a type of obstructive lung disease of the small airways, a form of chronic allograft rejection after lung transplantation. The most of lung transplant recipients who are long-term survivors develop bronchiolitis obliterans syndrome. It is estimated that more than 50% of recipients will develop some degree of BO within 5 years post-transplant, with an average time to diagnosis of 16 to 20 months after lung transplant, although it has been reported as early as 3 months after transplantation. Bronchiolitis obliterans characteristically presents with dyspnea and a cough that is persistent and progressive. Some may also have wheezing. Unlike asthma, these symptoms usually develop over weeks t...